Martin Salzmann
7PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 29, 2023
S100 as Serum Tumor Marker in Advanced Uveal Melanoma.Martin Salzmann, Alexander H Enk, Jessica C Hassel
|Mar 11, 2023
Tolerability of BRAF and MEK Inhibitors for Metastasized Melanoma after Intra-Class Switch: A Multicenter, Retrospective Study.Martin Salzmann, Alexander Wald, Henner Stege
|Nov 26, 2022
Response to First-Line Treatment with Immune-Checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry.Maximilian Haist, Henner Stege, Berenice Mareen Lang
|May 13, 2022
Long-term neurocognitive function after whole-brain radiotherapy in patients with melanoma brain metastases in the era of immunotherapy.Martin Salzmann, Klaus Hess, Kristin Lang
|Jul 14, 2021
Durable complete remission of leptomeningeal melanoma by intrathecal methotrexate maintained with systemic ipilimumab.Carmen Dietrich, Martin Salzmann, Andreas Steinbrecher
|Oct 21, 2020
Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma Patients.Martin Salzmann, Karolina Benesova, Kristina Buder-Bakhaya
Pageof 2
Frequent Collaborators
3 joint publications
Jessica C Hassel
1 joint publications
Holger Haenssle
1 joint publications
Maximilian Haist
1 joint publications
Selma Ugurel
1 joint publications
Michael Weichenthal
1 joint publications
Ralf Gutzmer
1 joint publications
Ulrike Leiter
1 joint publications
Sebastian Haferkamp
1 joint publications
Markus Heppt
1 joint publications
Christoffer Gebhardt
